Loading the company…
Loading the company…
Families: Bone graft & orthobiologics, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 6 decisions for Prosidyan (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (2). The latest was on 2025-10-22.
| Family | Decisions on record |
|---|---|
| Bone graft & orthobiologics | 10 |
| Lumbar fusion | 10 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-10-22 | 510(k) | K253147 | FIBERGRAFT BG Putty GPS Bone Graft Substitute FIBERGRAFT BG Putty Bone Graft Substitute FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute FIBERGRAFT BG Matrix Bone Graft Substitute |
| 2022-08-23 | 510(k) | K213803 | FIBERGRAFT Aeridyan Matrix Bone Graft Substitute |
| 2018-12-20 | 510(k) | K182670 | FIBERGRAFT AERIDYAN Matrix Bone Graft Substitute |
| 2018-04-06 | 510(k) | K180080 | FIBERGRAFT BG Matrix Bone Graft Substitute |
| 2017-06-30 | 510(k) | K171284 | FIBERGRAFT BG Matrix Bone Graft Substitute |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Prosidyan.